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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Prolonged air leak is the most common complication after thoracoscopic
operation for primary spontaneous pneumothorax (PSP), and the role of chemical pleurodesis
in treating air leaks remains unclear. This study evaluated the safety and efficacy of chemical
pleurodesis with a comparison between minocycline and OK-432.
Methods: Between 1994 and 2011, 1083 PSP patients were treated by thoracoscopic operation.
After the operation, patients with persistent air leak for 3 days or more were managed by min-
ocycline or OK-432 pleurodesis. The demographic and outcome data for these patients were
collected by retrospective chart review.
Results: Seventy-nine patients (7.3%) with prolonged air leak after thoracoscopy underwent
minocycline pleurodesis (60 patients) or OK-432 pleurodesis (19 patients) as the primary
treatment. The primary success rate was 63% (38/60) for minocycline pleurodesis and 95%
(18/19) for OK-432 pleurodesis (p Z 0.009). Postpleurodesis pain was common and compar-
able between the two groups. No major complications were noted after a total of 121 treat-
ments. Patients undergoing primary OK-432 pleurodesis had shorter durations of
postpleurodesis chest drainage (mean 8.5 vs. 2.3 days; p < 0.001) and postoperative hospital
stay (mean 11.9 vs. 6.8 days; p < 0.001) than those undergoing primary minocycline pleurod-
esis. After a median follow-up of 16 months, recurrence was noted in one patient in the OK-
432 group and none in the minocycline group. Long-term pulmonary function in the two
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Chemical pleurodesis for prolonged air leak in PSP 285Conclusion: Chemical pleurodesis using OK-432 or minocycline is safe and convenient for pro-
longed air leak after thoracoscopic treatment for PSP. Our experience suggested that OK-432
may be more effective than minocycline in reducing air leak.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Primary spontaneous pneumothorax (PSP) most commonly
occurs in young, tall, lean males.1 Advances in video-
assisted thoracoscopic surgery (VATS) that combine bul-
lectomy with some kind of pleurodesis, either abrasion or
pleurectomy, have provided a preferred intervention for
treating complicated or recurrent PSP.2e6 Unfortunately,
2e10% of PSP patients experience prolonged or refractory
air leak after surgical intervention, resulting in prolonged
tube thoracostomy and hospital stay, or even
reoperation.3e8
The optimal management for prolonged air leaks after
VATS in PSP patients is unclear because only a few of these
cases have been reported.3e8 Recently, chemical pleurod-
esis has been employed in an attempt to stop air leaks and
decrease the length of hospital stay after pulmonary
resection.7e9 Minocycline, a derivative of tetracycline, is
effective in inducing pleural fibrosis and adhesions in rab-
bits.10,11 In previous studies, we found that minocycline
pleurodesis is a safe and convenient procedure that is
associated with a lower rate of recurrence after thoraco-
scopic treatment of PSP.7,8 OK-432 (picibanil) is another
chemical irritant that has been used in sclerotherapy for
malignant pleural effusions and intractable pneumo-
thorax.12e14 Comparison of the safety and efficacy of the
two agents in treating prolonged air leak after VATS for PSP
has not previously been reported.
In the present study, we report our experience of using
minocycline and OK-432 pleurodesis for treating prolonged
air leak after thoracoscopic treatment of PSP. The safety
and efficacy of the two agents were also compared.Materials and methods
Study design and patients
The aim of this retrospective study was to evaluate the
safety and efficacy of minocycline and OK-432 as sclerosing
agents in patients with prolonged air leak after VATS for
PSP. To identify patients with prolonged air leak after VATS
for PSP, the medical records of all patients with sponta-
neous pneumothorax undergoing VATS in the Thoracic Sur-
gical Division between April 1994 and February 2011 were
screened. Patients aged >50 years or with pre-existing
pulmonary diseases were excluded from this study to avoid
patients with secondary pneumothorax. Prolonged air leak
was defined as air leak that persist for 3 or more days
requiring management after the operation. This study was
reviewed and approved by the Research Ethics Committee
of National Taiwan University Hospital (approval number
201202011RIC).VATS procedures
Either conventional or needlescopic VATS was performed
with the patient under general anesthesia and one-lung
ventilation. The anesthesia, preparation, and operative
procedures of the needlescopic VATS were almost identical
to conventional VATS. Previous studies have shown that the
short-term results and pneumothorax recurrence rates in
both techniques are comparable, even though needlescopic
VATS provides better cosmetic results and induces less
residual chest pain.4,15
Under thoracoscopy, pleural adhesions were freed using
electrocautery. When blebs were identified, they were
excised with an endoscopic stapler. Blind apical stapling
was done at the most suspicious area if no bleb could be
identified. Mechanical pleurodesis was performed using
pleural abrasion or apical pleurectomy, depending on the
treatment policies of different surgeons or clinical trial
protocols during different time periods.3 For thoracoscopic
apical pleurectomy, the parietal pleura above the fifth rib
were excised. For thoracoscopic pleural abrasion, the
parietal surface above the sixth rib was abraded by
inserting the curved dissector with a diathermy scratch
pad.3 After postoperative lung reinflation, normal saline
solution was instilled to check for air leaks. A chest tube
(28F) was placed in the apex through one of the insertion
wounds.
The patients were extubated in the operating room and
observed for 1e2 hours in the recovery room. Chest radi-
ography (CXR) was performed immediately after surgery or
the next morning. The chest tube was connected to a low-
pressure suction system (10 cmH2O) if the lung was not
fully expanded.
Chemical pleurodesis with minocycline and OK-432
When prolonged air leak occurred, chemical pleurodesis
using minocycline or OK-432 was selected as the primary
treatment. The attending surgeon made the choice
between the two agents. The cost of OK-432 pleurodesis is
higher in Taiwan because the national health insurance
does not reimburse this treatment. In patients with per-
sistent air leak, pleurodesis was repeated using the same or
the other agent.
For minocycline pleurodesis, 20 mL of 2% lidocaine
hydrochloride (400 mg) was instilled into the pleural cavity
through the thoracostomy tube, followed by a solution of
300 mg or 400 mg (7 mg/kg) minocycline (Mirosin; Taiwan
Panbiotic Laboratories, Kaohsiung, Taiwan) in 20 mL of
normal saline. For OK-432 pleurodesis, 20 mL of 2% lido-
caine hydrochloride (400 mg) was instilled, followed by a
solution of 20 mL of normal saline containing 5e10 KE of
OK-432 (KE Z Klinische Einbeit; 1 KE contains 0.1 mg of
286 C.-H. How et al.dried cocci; Chugai Pharmaceutical Co, Tokyo, Japan). The
rubber tube connecting the chest tube and chest bottle was
raised 40e60 cm above the patient to trap the sclerosing
agent but allow air to pass under pressure. Patients were
repositioned every 30 minutes so that the sclerosing agent
could contact all pleural surfaces. Side effects and com-
plaints of the patients were recorded. The rubber tube was
lowered 6e8 hours later for minocycline and 2 hours later
for OK-432.
The intensity of postoperative pain was evaluated by
using the visual analogue scale (VAS; 0 represented no pain
and 10 represented intractable pain) three times/day after
the pleurodesis. Intramuscular meperidine hydrochloride
(Demerol, 50 mg/ampule) was administered every 4e6
hours as needed if the pain became intolerable, pain could
not be relieved by oral analgesics, and VAS was >7. CXR was
performed the next day after pleurodesis, and after ces-
sation of the air leak. In both groups, the tube was removed
in both groups when the lung was fully expanded and no air
leak was noted in a 24-hour period.
All complications after pleurodesis were recorded. Fever
was defined as body temperature >38C after pleurodesis.
Loculated effusions were defined as loculated pleural
effusions on CXR and sonography after pleurodesis. Suc-
cessful treatment was defined as cessation of air leak after
pleurodesis with no additional intervention required. Fail-
ure was defined as persistent air leak after pleurodesis
requiring additional intervention such as repeat pleurod-
esis. Repeat pleurodesis was performed in patients with
persistent air leak 3 days after the initial chemical
pleurodesis.
Follow-up and pulmonary function analysis
After discharge from the hospital, patients were followed
at the outpatient clinics at 1 week, 1 month, 3 months, and
6 months, and then every 6 months where chest radiog-
raphy was performed. Follow-ups were also conducted
every 6 months by a registered nurse according to a
standard questionnaire that included questions on whether
a recurrence occurred, when it happened, and how it was
treated. Pulmonary function tests were performed for
patients able to attend a hospital outpatient appointment
after at least 6 months. Forced vital capacity and forced
expiratory volume in 1 second were measured using a spi-
rometer (Microspiro HI-298; Chest Corporation, Tokyo,
Japan) in the seated position. A minimum of three
acceptable forced expiratory maneuvers were performed,
with the best selected for analysis.
Data collection and analysis
Clinical data, operative findings, air leak status, methods
and times of pleurodesis, requested doses of meperidine
and VAS data, complications, duration of chest tube
drainage, and length of hospital stay were collected
through retrospective chart review and documentation of
database information. Continuous variables such as age or
height are expressed as mean  standard deviation and
analyzed by nonparametric ManneWhitney U testing. Cat-
egorical variables such as sex or smoking status werepresented by frequency (%) and analyzed by Fisher’s exact
teat. A p value of <0.05 was considered significant for all
tests.Results
Between April 1994 and February 2011, a total of 1083
patients with PSP were treated by VATS. After the oper-
ation, 79 patients (7.3%) had prolonged air leaks and
chemical pleurodesis was used. Among them, 60 patients
underwent minocycline pleurodesis (minocycline group)
and 19 patients underwent OK-432 pleurodesis (OK-432
group) as their primary treatment. The mean dose of
instillation was 325.0  43.6 mg in the minocycline group
and 7.1  2.5 KE in the OK-432 group. The clinical char-
acteristics and operative findings of the patients are shown
in Table 1. The two groups were comparable in terms of
age, sex, body mass index, smoking status, side involve-
ment, surgical indications, bleb number, and the method of
mechanical pleurodesis during VATS.
The treatment results of patients using minocycline or
OK-432 as the primary treatment are summarized in Table 2.
Chest pain was the most common complaint after chemical
pleurodesis, with severe pain that required immediate
meperidine injection occurring in 62% in the minocycline
group and 68% in the OK-432 group (p Z 0.786). The mean
VAS of the first and second postpleurodesis days and accu-
mulated doses of meperidine of the two groups were com-
parable. Complications, including fever and loculated
pleural effusions, were noted in five patients (8.3%) with
minocycline pleurodesis and four patients (21%) with OK-432
pleurodesis. Fever resolved after the administration of
acetaminophen. One patient developed loculated effusions
that resolved gradually with conservative treatment.
Successful treatment of air leak was achieved in 38
patients (63.3%) when minocycline was used as the primary
treatment, and in 18 patients (94.7%) when OK-432 was
used as the primary treatment (pZ 0.009; Table 2, Fig. 1).
Among the 22 minocycline-group patients in whom primary
treatment was unsuccessful, 12 underwent repeat mino-
cycline pleurodesis as the secondary treatment; however,
this treatment was also unsuccessful (0% successful rate).
The remaining 10 patients underwent OK-423 pleurodesis as
the secondary treatment and cessation of air leak was
successfully achieved in 90% (9/10 patients). One patient in
the OK-432 group, in whom primary treatment was unsuc-
cessful, underwent another OK-432 pleurodesis, which was
successful. In summary, the success rates of minocycline
and OK-432 were 0/12 treatments and 10/11 treatments,
respectively (0% vs. 91%; p < 0.001; Fig. 1), when used as
secondary treatments. The 13 patients who failed secon-
dary treatment underwent a total of 19 subsequent mino-
cycline or OK-432 treatments. In total, the 79 patients
underwent 121 pleurodesis treatments, including 85 mino-
cycline treatments and 36 OK-432 treatments.
When the durations of chest tube drainage and hospi-
talization were compared, patients undergoing OK-432
pleurodesis as the primary treatment had shorter dura-
tions of post-pleurodesis chest drainage (mean, 8.5 vs. 2.3
days; p < 0.001), postoperative chest drainage (mean, 10.2
vs. 5.2 days; p < 0.001), and postoperative hospital stay
Table 1 Clinical characteristics and operative findings of patients using minocycline or OK-432 as the primary treatment.
Minocycline group (n Z 60) OK-432 group (n Z 19) p
Age, y 25.7  8.6 29.0  7.7 0.123
Males 43 (71.7%) 14 (73.7%) 0.531
Body height, cm 171.5  10.0 171.3  6.5 0.958
Body mass index 18.4  2.0 19.4  3.1 0.450
Smoking 15 (25.0%) 7 (36.8%) 0.381
Left side involved 30 (50.0%) 9 (47.4%) 1.000
Surgical indications
Recurrent pneumothorax 37 (61.7%) 13 (68.4%) 0.724
Persistent air leaks 13 (21.7%) 4 (21.1%)
Uncomplicated first episode 7 (11.7%) 1 (5.3%)
Hemopneumothorax 1 (1.7%) 1 (5.3%)
Bilateral pneumothorax 2 (3.3%) 0 (0%)
Bleb number
None 2 (3.3%) 2 (10.5%) 0.389
Single 32 (53.3%) 8 (42.1%)
Multiple 26 (43.3%) 9 (47.3%)
Mechanical pleurodesis
Abrasion 52 (86.7%) 13 (68.4%) 0.089
Apical pleurectomy 8 (13.3%) 6 (31.6%)
Data are presented as mean  standard deviation or n (%).
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going minocycline pleurodesis as primary treatment (Table
2). After a median follow-up of 16 months, recurrent
pneumothorax was noted in one patient in the OK-432
group and none in the minocycline group. The pneumo-
thorax resolved spontaneously during two weeks of obser-
vation. To evaluate the long-term effects of chemical
pleurodesis on pulmonary function, spirometric measure-
ments were performed in 13 patients. There was no sig-
nificant difference between the minocycline and OK-432
groups (Table 2).Table 2 Results in patients using minocycline or OK-432 as the
Minocycline group (n Z
Meperidine requested 37 (61.7%)
Dose of meperidine, mg 112.7  174.0
Postoperative pain (VAS)
First pleurodesis day 3.3  1.3
Second pleurodesis day 3.4  2.1
Complications 5 (8.3%)
Fever 4 (6.7%)
Loculated effusions 1 (1.7%)
Successful primary treatment 38 (63.3%)
Post-pleurodesis tube stay, d 8.5  4.8
Postoperative tube stay, d 10.2  5.2
Postoperative hospital stay, d 11.9  6.1
Recurrence 0 (0%)
Pulmonary function test (%)*
FVC 86.7  6.9
FEV1.0 88.6  8.7
Data are presented as mean  standard deviation or n (%).
*Minocycline group: nZ 8; OK-432 group: nZ 5. FEV1.0Z forced ex
analogue scale.Discussion
Prolonged air leaks are a significant cause of morbidity and
increased hospital stay and cost after pulmonary
resection.9,16e19 Prolonged air leak is also the most com-
mon complication after thoracoscopic treatment for PSP.
The definition of prolonged air leaks has been described as
air leaks that persist for more than 3e7 days after treat-
ment of PSP.3e8 In this study, 3 days was chosen because
the median length of postoperative stay of the 1083 PSPprimary treatment.
60) OK-432 group (n Z 19) p
13 (68.4%) 0.786
59.9  79.0 0.205
3.9  2.3 0.963
2.7  1.0 0.557
4 (21%) 0.207
4 (21%) 0.090
0 (0%) 1.000
18 (94.7%) 0.009
2.3  1.8 <0.001
5.0  2.6 <0.001
6.8  4.6 <0.001
1 (5.3%) 0.241
81.2  16.0 0.661
80.9  18.8 0.464
piratory volume in 1 s; FVCZ forced vital capacity; VASZ visual
Figure 1 Flow chart representation of patient selection, treatment allocation, and outcome. VATS Z video-assisted thoraco-
scopic surgery.
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pleurodesis could be safely used in these patients. Our
results also showed that OK-432 was more effective than
minocycline in diminishing air leaks, irrespective of its use
in primary or secondary treatment.
Prolonged postoperative air leak in PSP can be caused by
missed leaking blebs or unsatisfactory healing of the
endoscopic suturing after thoracoscopic surgery. The
treatment options for prolonged air leaks in these patients
include observation, Heimlich valve placement, chemical
pleurodesis, and reoperation.2e8,20,21 Chemical pleurodesis
is more attractive because it is simple and noninvasive, and
can be effective to shorten the duration of air leaks. In this
study, we have reported on 79 PSP patients who underwent
121 rounds of minocycline or OK-432 pleurodesis as the
primary or salvage treatment for persistent air leak. There
were no significant adverse events related to the sclerosing
agents and reoperation was not required in any of our
patients.
Many chemical irritants (minocycline, OK-432, and talc)
have been used to hasten the healing of air leaks or to
decrease the rate of recurrence in the nonsurgical treat-
ment of spontaneous pneumothorax. Talc pleurodesis is
safe and effective in PSP management,22,23 but it was not
available to us. Therefore, in this study, minocycline and
OK-432 were selected for chemical pleurodesis because
they are easily administered, safe, relatively inexpensive,
and easily available. Minocycline has been used for 15 years
in our hospital. Our data have demonstrated that minocy-
cline pleurodesis is safe and effective in inducing pleural
adhesions in animals and reducing the rate of recurrence
after VATS for PSP patients.3,7,8,11,24 While the role ofminocycline in prolonged air leak is controversial, many of
our staff tend to select it as the primary treatment for
prolonged air leaks. OK-432 (picibanil), a lyophilized mix-
ture of a low virulence strain (Su) of Streptococcus pyo-
genes incubated with benzylpenicillin, has been used in
sclerotherapy for neck lymphangioma, malignant pleural
effusion, and intractable pneumothorax with satisfactory
results.12e14 In our hospital, OK-432 was initially used as
salvage treatment for prolonged, intractable air leaks after
failure of minocycline. In recent years, we have started to
use OK-432 as the primary treatment for prolonged air leaks
and have found that it is also safe and effective.
Chest pain was the most common compliant associated
with minocycline and OK-432 pleurodesis. Even with a large
dose of intrapleural lidocaine (400 mg), meperidine injec-
tion was requested by many of our patients to relieve
severe pain. The degree of chest pain with the two thera-
pies seems to be comparable because the accumulated
dose of meperidine and postoperative VAS scores were not
significantly different between the two groups. In addition
to chest pain, fever is very common after chemical pleu-
rodesis, particularly after OK-432 instillation (21%). In our
experience, fever and chills usually developed several
hours after OK-432 administration, but resolved within 1
day after treatment with acetaminophen. Another concern
with chemical pleurodesis is empyema. In our study pop-
ulation, which underwent 121 rounds of pleurodesis, only
one patient developed loculated effusions. Our results
suggest that the incidence of pleural infection after mino-
cycline or OK-432 is very low.
In our experience, the benefits of chemical pleurodesis
for PSP after VATS are multiple. In addition to reducing the
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durations of air leaks and hospital stay.7,8,25 We suggest
that chemical pleurodesis can be freely used when persis-
tent postoperative air leaks occur.
Success rates of the primary and secondary treatments
with OK-432 for prolonged air leak were 95% (18/19) and
91% (10/11), respectively, while success rates of the pri-
mary and secondary treatments with minocycline were 63%
(38/60) and 0% (0/12), respectively. Our results suggest
that OK-432 may induce a more intense pleurodesis than
minocycline. In theory, a more intense pleurodesis may
result in constrictive pulmonary dysfunction. However, the
results of pulmonary function tests between the two groups
were not significantly different. It is possible that the
number of patients who underwent pulmonary function
tests in this study was so small that statistical significance
could not be reached.
In addition to chemical pleurodesis, another treatment
option for prolonged air leak is reoperation. Although
reoperation may provide a more secure way to seal the
leakage of the lung, it was not used in our patients because
it represented treatment failure of the first operation and
further complications might develop. Chemical pleurodesis,
however, provides a safe, convenient, and less invasive
alternative in managing postoperative air leak, although
the efficacy should be determined by future studies.
There are limitations to this study. It is a retrospective
study of a group of patients treated by different surgeons
over a 17-year period. Treatment policy in patients with
prolonged air leak was not standardized and might be
modified over time. There is a discrepancy of patient
numbers between the two pleurodesis groups, making a
reliable comparison impossible. We believe that a pro-
spective study with precise definition of variables and
standardized treatment protocol will be helpful in vali-
dating our results.
In conclusion, this study demonstrates that chemical
pleurodesis using minocycline or OK-432 is safe and con-
venient for prolonged air leak after thoracoscopic treat-
ment for PSP. Our results also showed that OK-432 seems to
be more effective than minocycline in shortening the
durations of air leak and hospital stay.Acknowledgments
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